• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients

Research Project

Project/Area Number 23790886
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Circulatory organs internal medicine
Research InstitutionKurume University

Principal Investigator

OHTSUKA MASANORI  久留米大学, 医学部, 助教 (30461429)

Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords血管新生細胞 / 血小板由来膜小胞体 / RANTES / 血管新生 / 循環器内科学 / 分子血管病態学 / 血管内皮前駆細胞
Research Abstract

We investigated whether PMPs could augment the neovascularization. We isolated mononuclear cells and PMPs from atherosclerotic patient-derived peripheral blood and generated PMP-pretreated CACs(PMP-CACs) by co-culture of the mononuclear cells and PMPs. The adhesion capacity of PMP-CACs was greater to that of CACs. PMPs released RANTES into the culture medium. Intravenous injection of PMP-CACs to rats with hindlimb ischemia augmented neovascularization of the ischemic limbs more than the injection of CACs.The number of PMP-CACs incorporated into the capillaries of the ischemic limbs was greater than that of incorporated CACs.The augmented adhesion and neovascularization capacities by PMP-CACs were canceled out by a RANTES neutralizing antibody.
PMP-secreted RANTES may play role in the augmenting adhesion and neovascularization capacities of CACs. Injection of PMP-CACs may be a new strategy to augment the effects of therapeutic angiogenesis for limb ischemia in atherosclerotic patients.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (5 results)

All 2013 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (3 results)

  • [Journal Article] Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients2013

    • Author(s)
      大塚昌紀、佐々木健一郎、今泉勉
    • Journal Title

      Atherosclerosis

      Volume: 227巻 Issue: 2 Pages: 275-282

    • DOI

      10.1016/j.atherosclerosis.2013.01.040

    • Related Report
      2013 Annual Research Report 2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients2013

    • Author(s)
      大塚 昌紀
    • Journal Title

      Atherosclerosis

      Volume: 227 Pages: 275-282

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients2013

    • Author(s)
      大塚昌紀
    • Organizer
      第76回日本循環器学会学術集会
    • Place of Presentation
      福岡国際会議場
    • Year and Date
      2013-03-18
    • Related Report
      2013 Final Research Report
  • [Presentation] Platelet-derived microparticles augmented neovascularization capacities of endothelial progenitor cells

    • Author(s)
      大塚 昌紀
    • Organizer
      第76回日本循環器学会学術集会
    • Place of Presentation
      福岡国際会議場
    • Related Report
      2012 Research-status Report
  • [Presentation] 血小板由来膜小胞体は血管内皮前駆細胞の血管新生能力を増強させた

    • Author(s)
      大塚 昌紀
    • Organizer
      第76回日本循環器学会学術集会
    • Place of Presentation
      福岡国際センター
    • Related Report
      2011 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi